Alpha Teknova, Inc.
NASDAQ:TKNO · NASDAQ Global Market
+$0.23 today
Vol 0.52M · Avg 0.13M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Stock Ticker Earnings Waterfall
NASDAQ:TKNO · Revenue to Net Income
Key Ratios
Analysis
$41.8M of revenue converted into -$17.2M of net income for the selected period. Gross margin is 33.4% and net margin is -41.1%, showing how much revenue survives after costs and taxes. EPS is $-0.32, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $40.5M +7.4% | $37.7M +2.9% | $36.7M -11.4% | $41.4M +12.3% | $36.9M | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $27.1M -11.3% | $30.5M +15.6% | $26.4M +10.2% | $23.9M +24.2% | $19.3M | $725.6M | $804.0M | $882.4M |
| Gross Profit | $13.4M +85.9% | $7.2M -29.8% | $10.3M -41.1% | $17.5M -0.8% | $17.6M | $8.9B | $7.6B | $6.2B |
| Gross Margin | 33.2% +14.0pp | 19.2% -8.9pp | 28.1% -14.1pp | 42.2% -5.6pp | 47.8% | 9.8% | 28.9% | 38.3% |
| Research & Development | $2.2M -20.4% | $2.8M -50.4% | $5.6M -28.0% | $7.7M +79.4% | $4.3M | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $27.1M -8.1% | $29.5M -15.3% | $34.8M -7.1% | $37.4M +54.9% | $24.2M | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $30.4M -8.9% | $33.4M -27.2% | $45.9M -31.7% | $67.1M +126.6% | $29.6M | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $6.3M -3.6% | $6.6M +16.2% | $5.7M +78.8% | $3.2M +9.8% | $2.9M | $374.2M | $1.2B | $631.8M |
| EBITDA | -$10.1M +48.1% | -$19.6M +23.4% | -$25.5M +0.6% | -$25.7M -180.3% | -$9.2M | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | -25.0% +26.8pp | -51.8% +17.8pp | -69.6% -7.6pp | -62.0% -37.2pp | -24.8% | 5.6% | 46.3% | 42.0% |
| Operating Income | -$17.0M +35.1% | -$26.1M +26.5% | -$35.6M +28.4% | -$49.7M -313.5% | -$12.0M | $12.3B | $14.0B | -$15.7B |
| Operating Margin | -41.9% +27.4pp | -69.3% +27.7pp | -96.9% +22.9pp | -119.9% -87.3pp | -32.5% | 16.6% | 24.1% | 22.0% |
| Interest Income | $0 | $0 | $0 -100.0% | $213.0K | $0 | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $710.0K +3.3% | $687.0K -17.5% | $833.0K | $0 -100.0% | $589.0K | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | -$225.0K +67.2% | -$687.0K +54.7% | -$1.5M -665.3% | $268.0K +142.6% | -$629.0K | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | -$17.2M +35.9% | -$26.8M +27.6% | -$37.1M +24.9% | -$49.4M -290.8% | -$12.6M | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | -42.5% +28.6pp | -71.1% +30.0pp | -101.1% +18.2pp | -119.2% -85.0pp | -34.3% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $58.0K +165.9% | -$88.0K +70.5% | -$298.0K +84.5% | -$1.9M +32.1% | -$2.8M | $1.3B | -$1.6B | $745.2M |
| Net Income | -$17.3M +35.5% | -$26.7M +27.3% | -$36.8M +22.5% | -$47.5M -384.2% | -$9.8M | $4.9B | $4.8B | $4.7B |
| Net Margin | -42.6% +28.3pp | -70.9% +29.4pp | -100.3% +14.3pp | -114.6% -88.0pp | -26.6% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | -$0 +43.9% | -$1 +50.9% | -$1 +31.4% | -$2 -382.9% | -$0 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | -$0 +43.9% | -$1 +50.9% | -$1 +31.4% | -$2 -382.9% | -$0 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $53.5M +14.4% | $46.7M +46.9% | $31.8M +13.3% | $28.1M +0.3% | $28.0M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $53.5M +14.4% | $46.7M +46.9% | $31.8M +13.3% | $28.1M +0.3% | $28.0M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
BioAge Labs, Inc.
NASDAQ:BIOA
$776.34M
Ironwood Pharmaceuticals, Inc.
NASDAQ:IRWD
$578.78M
Canopy Growth Corporation
NASDAQ:CGC
$405.23M
NeoGenomics, Inc.
NASDAQ:NEO
$286.08M
Lifecore Biomedical, Inc.
NASDAQ:LFCR
$208.93M
ProQR Therapeutics N.V.
NASDAQ:PRQR
$194.39M
Aurora Cannabis Inc.
NASDAQ:ACB
$165.87M
CVRx, Inc.
NASDAQ:CVRX
$131.62M
Exagen Inc.
NASDAQ:XGN
$105.58M
Immutep Limited
NASDAQ:IMMP
$55.46M
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does TKNO generate?
Alpha Teknova, Inc. (TKNO) reported $40.52M of revenue in fiscal 2025.
Is TKNO profitable?
Alpha Teknova, Inc. (TKNO) reported -$17,259,000.00 of net income, with a net margin of -42.6%.
Explore More
Continue the stock analysis
Jump to another research area for this company.